Latest News

Recent share performance and business snapshot With no single headline event driving attention to Veris Residential (VRE), the recent share performance itself is the focus, as the stock shows double digit returns over the past month and past 3 months. Veris Residential is a real estate investment trust focused on Class A multifamily properties in the Northeast. It uses a technology enabled, vertically integrated platform to manage, operate, acquire, and develop its portfolio for residents and...

Sino Biopharmaceutical (SEHK:1177) has drawn fresh investor attention after signing an exclusive global license agreement with Sanofi for its JAK/ROCK inhibitor rovadicitinib, tied to upfront, milestone and royalty payments. See our latest analysis for Sino Biopharmaceutical. The Sanofi licensing news arrives at a time when Sino Biopharmaceutical’s shares trade at HK$6.13, with a 1 day share price return of 3.72% and a year to date share price return decline of 3.62%. However, a 1 year total...

Sheng Siong Group Ltd has released its full-year 2025 results, reporting sales of S$1,569.96 million and net income of S$149.46 million, both higher than the previous year. The uplift in basic earnings per share to S$0.0994 from S$0.0915 highlights improved profitability on a per-share basis for investors. Next, we examine how Sheng Siong's full-year revenue growth and stronger earnings shape the company’s investment narrative going forward. Explore 22 top quantum computing companies leading...

Certara recently highlighted that its Simcyp physiologically-based pharmacokinetic modeling was accepted by the U.S. FDA in place of multiple clinical pharmacology studies to support the new drug application for asciminib (Scemblix®), an allosteric BCR::ABL1 inhibitor for Chronic Myeloid Leukemia. This decade-long modeling effort, which replaced at least ten dedicated clinical studies and informed dosing and drug-interaction decisions, underscores how biosimulation can cut development costs...

PYC Therapeutics Limited recently completed a follow-on equity offering raising about A$584.14 million, issuing multiple tranches of ordinary shares at A$1.50 each, including a rights issue and subsequent direct listing on the ASX. The capital raise, combined with the recent half-year results showing lower revenue and a reduced net loss, materially reshapes PYC’s funding profile and ownership structure as it progresses its therapeutic programs. We’ll now examine how this large equity...

TBS HOLDINGS, CJ ENM and U-NEXT HOLDINGS Ltd (TSE:9418) have agreed to form a joint venture in Japan to plan, invest in and develop audio visual content IPs across Japanese and Korean markets. See our latest analysis for U-NEXT HOLDINGSLtd. U-NEXT HOLDINGS Ltd’s share price has eased this year, with a 1-day share price return of 0.68% contrasting with a 90-day share price return decline of 7.99%. Its 5-year total shareholder return of 180.51% points to strong long-term compounding and...

MarketAxess Holdings Inc. recently appointed William Quan as Chief Technology Officer, tasking him with modernizing its global technology platforms and embedding AI and advanced data capabilities across the business. By bringing in a leader with deep experience in electronic trading and AI-driven platforms from firms like Amazon Web Services, J.P. Morgan, and Deutsche Bank, MarketAxess is signaling a stronger push to enhance its bond-trading technology and product innovation. With William...

In recent days, investor concerns about regional banks’ exposure to the opaque private credit market have weighed on The Bancorp, amid broader sector jitters following defaults and loan write-offs in that space. These worries come on top of earlier pressure from weaker quarterly results and a shrinking net interest margin, even as The Bancorp has built a niche in specialized fintech-focused banking and lending solutions. Next, we’ll examine how heightened worries about private credit...

Why Signify’s new UltraShine launch matters for the stock Signify (ENXTAM:LIGHT) has drawn fresh attention after launching its Philips UltraShine downlights, marketed as a next-generation range with 150 lumens per watt efficiency and advanced optical and heat management features. See our latest analysis for Signify. At around €18.50, Signify’s recent 7 day share price return of 6.19% and year to date share price return of 14.43% point to pressure on momentum. However, the 1 year total...

In February 2026, Xylem Inc. announced that its Board of Directors had approved a new share repurchase program, authorizing the company to buy back up to US$1.50 billion of its own stock with no expiration date. This move follows the completion of a prior authorization under which Xylem repurchased 5,200,000 shares for US$321.90 million, highlighting an ongoing preference for returning capital to shareholders alongside reinvestment in the business. We’ll now explore how this sizable,...

In late February 2026, SS&C Technologies Holdings, Inc. reported an 8.1% year-on-year revenue increase that exceeded analyst expectations and raised its full-year EPS and revenue guidance, citing strong execution and the breadth of its software and services portfolio. A few days earlier, SS&C announced a generative AI-powered sales enablement solution developed with Thornburg Investment Management, embedding advisor insights directly into CRM systems to streamline how asset managers prepare...

Why Redcare Pharmacy’s latest earnings moved the stock Redcare Pharmacy (XTRA:RDC) shares reacted sharply after the company reported full year 2025 earnings, with higher sales of €2.94b, a narrower net loss of €37.7m, and fresh guidance for 2026. The market response, including a 21.01% one day drop in the share price, reflected investor focus on margin pressures, mixed cash flow signals, and how the new growth targets might affect profitability. See our latest analysis for Redcare...

In February 2026, Leon's Furniture Limited reported full-year 2025 results showing sales of C$2,573.72 million and net income of C$157.05 million, alongside slightly higher basic and diluted earnings per share from continuing operations compared with the prior year. On the same day, the board not only maintained its regular quarterly dividend of C$0.24 per share but also declared a C$0.50 special dividend, which underscores management’s confidence in the company’s balance sheet and cash...

Tabcorp Holdings reported past half-year results to 31 December 2025, with revenue rising slightly to A$1,344.9 million while net profit eased to A$21.7 million, and basic earnings per share from continuing operations slipped to A$0.009. Despite the softer earnings, the company lifted its interim unfranked dividend by 50% to A$0.015 per share, signalling a more generous capital return stance that may reshape how investors view its payout policy and cash flow priorities. We’ll now examine how...

ANYCOLOR Inc. recently reported a Q4 earnings beat, with management pointing to stronger content, subscription, and merchandising revenues as key drivers of the outperformance. An interesting takeaway from the results is how improved monetization of NIJISANJI-related content and events appears to be strengthening the company’s overall profitability profile. With recent share gains, we will examine how stronger content monetization and subscription growth could shape ANYCOLOR’s investment...

Why Terumo’s new cell and gene therapy blueprint matters for shareholders Terumo (TSE:4543) is drawing attention after its Blood and Cell Technologies unit introduced a C> Ecosystem Blueprint to support cell and gene therapy developers in Asia Pacific, focusing on workflows, capabilities, and collaborative partnerships. See our latest analysis for Terumo. Terumo’s 1 day share price return of 4.33% to ¥2,061 comes after a period of weaker momentum, with a 90 day share price return of 13.02%...

Why Brixmor Property Group Stock Is On Investors’ Radar Brixmor Property Group (BRX) has drawn fresh attention after recent trading left the stock with a month return of 6.2% and a past 3 months move of 21.9%, prompting closer scrutiny of the REIT’s fundamentals. See our latest analysis for Brixmor Property Group. At a share price of US$30.07, Brixmor’s recent 6.2% 1 month and 21.9% 3 month share price returns contrast with some softer short term moves. Its 1 year and multi year total...

China Everbright (SEHK:165) is back in focus after a boardroom reshuffle, with Chairman Yu Fachang stepping down, President Lin Chun moving into the Chairman role, and Pan Jianyun taking over as Acting President. See our latest analysis for China Everbright. The leadership reshuffle comes after a mixed price pattern, with a 3.1% 1 day share price return to HK$8.32 contrasting with a 12.42% year to date share price decline. However, the 1 year total shareholder return of 64.63% points to...

DT Midstream (DTM) has drawn fresh attention after reporting 17% year-over-year adjusted EBITDA growth for 2025, expanding its Pipeline segment to 70% of the business and raising its quarterly dividend by 7.3%. See our latest analysis for DT Midstream. The latest operational update seems to line up with recent market interest, with a 30 day share price return of 10.1% and a 90 day share price return of 17.5%. The 1 year total shareholder return of 65.6% and 3 year total shareholder return of...

Why Clinuvel’s latest half year result has caught investor attention Clinuvel Pharmaceuticals (ASX:CUV) has drawn fresh interest after reporting half year earnings to 31 December 2025, with revenue of A$40.56 million and net income of A$10.44 million, both below the prior period. See our latest analysis for Clinuvel Pharmaceuticals. At a share price of A$10.16, Clinuvel’s recent half year result lands against a backdrop of weaker momentum, with a 30 day share price return of 8.14% and a 90...

Bumitama Agri (SGX:P8Z) drew investor attention on 7 March 2026 after a 6.82% intraday move, with trading volumes rising alongside firmer crude palm oil prices and improving sentiment toward agricultural producers. See our latest analysis for Bumitama Agri. That sharp 6.82% 1 day share price return at a latest share price of S$1.41 comes after a softer 1 month share price return of 2.76% decline. At the same time, the 1 year total shareholder return of 78.76% and very large 5 year total...

Why MAAS Group Holdings Just Drew Fresh Attention MAAS Group Holdings (ASX:MGH) has come into focus after reporting half year results to 31 December 2025 and confirming a new distribution, giving investors fresh numbers to assess both earnings and income potential. See our latest analysis for MAAS Group Holdings. The latest half year earnings and new A$0.035 per share distribution have arrived alongside a 30 day share price return of 18.10% and a 1 year total shareholder return of 34.18%. The...

Why ENN Energy Holdings Just Drew Investor Attention ENN Energy Holdings (SEHK:2688) has come into focus after a recent move in its share price, with the stock closing at HK$68.30 as investors reassess its role in China’s gas infrastructure market. See our latest analysis for ENN Energy Holdings. The recent 1 day share price return of a 2.15% decline and 7 day share price return of a 0.73% decline sit against a 1 year total shareholder return of 33.69%. However, longer term total shareholder...

In early March 2026, SES AI Corporation reported full-year 2025 results showing sales of US$21.00 million, a smaller net loss of US$73.04 million, a Q4 revenue shortfall versus expectations, and new 2026 revenue guidance of US$30.00 million to US$35.00 million alongside a projected reset in gross margins. The earnings release also revealed a pivot away from automotive battery mass production toward energy storage systems, drones, and materials, while logistics-driven shipment delays and...